Common variants in psychiatric risk genes predict brain structure at birth

Cerebral Cortex

Volumn 24, Issue 5, 2014, Pages 1230-1246

  Knickmeyer, Rebecca C ^a   Wang, Jiaping ^b   Zhu, Hongtu ^b   Geng, Xiujuan ^a   Woolson, Sandra ^a   Hamer, Robert M ^a,b   Konneker, Thomas ^d   Lin, Weili ^a   Styner, Martin ^a,c   Gilmore, John H ^a  

^a UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

^b The University of North Carolina at Chapel Hill   (United States)

^c CB 3175 Sitterson Hall   (United States)

^d University of California   (United States)

Author keywords

catechol O methyltransferase; cortex; disrupted in schizophrenia 1; neonate; neuroimaging

Indexed keywords

APOLIPOPROTEIN E; BRAIN DERIVED NEUROTROPHIC FACTOR; CATECHOL METHYLTRANSFERASE; DISRUPTED IN SCHIZOPHRENIA 1 PROTEIN; ESTROGEN RECEPTOR ALPHA; GLUTAMATE DECARBOXYLASE; NEU DIFFERENTIATION FACTOR; GLUTAMATE DECARBOXYLASE 1;

ADOLESCENT; ADULT; ALLELE; ARTICLE; BRAIN; BRAIN DEVELOPMENT; BRAIN SIZE; BRAIN TISSUE; FEMALE; FRONTAL LOBE; GENE FREQUENCY; GENETIC VARIABILITY; GENOTYPE; GRAY MATTER; HIPPOCAMPUS; HOMOZYGOSITY; HUMAN; MALE; NEWBORN; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; PSYCHIATRY; SINGLE NUCLEOTIDE POLYMORPHISM; TEMPORAL CORTEX; VOLUMETRY; BRAIN MAPPING; CHILD; GENETIC PREDISPOSITION; GENETICS; GROWTH, DEVELOPMENT AND AGING; IMAGE PROCESSING; MENTAL DISEASE; MIDDLE AGED; PATHOLOGY; PREDICTIVE VALUE; PREGNANCY; YOUNG ADULT;

ADOLESCENT; ADULT; BRAIN; BRAIN MAPPING; CHILD OF IMPAIRED PARENTS; FEMALE; GENETIC PREDISPOSITION TO DISEASE; GENETIC VARIATION; GENOTYPE; GLUTAMATE DECARBOXYLASE; HUMANS; IMAGE PROCESSING, COMPUTER-ASSISTED; INFANT, NEWBORN; MAGNETIC RESONANCE IMAGING; MALE; MENTAL DISORDERS; MIDDLE AGED; POLYMORPHISM, SINGLE NUCLEOTIDE; PREDICTIVE VALUE OF TESTS; PREGNANCY; YOUNG ADULT;

EID: 84898870011     PISSN: 10473211     EISSN: 14602199     Source Type: Journal    
DOI: 10.1093/cercor/bhs401     Document Type: Article

References (131)

1. Addington AM, Gornick M, Duckworth J, Sporn A, Gogtay N, Bobb A, Greenstein D, Lenane M, Gochman P, Baker N et al. 2005. GAD1 (2q31.1), which encodes glutamic acid decarboxylase (GAD67), is associated with childhood-onset schizophrenia and cortical gray matter volume loss. Mol Psychiatry. 10:581-588.
2. Addington AM, Gornick MC, Shaw P, Seal J, Gogtay N, Greenstein D, Clasen L, Coffey M, Gochman P, Long R et al. 2007. Neuregulin 1 (8p12) and childhood-onset schizophrenia: susceptibility haplo-types for diagnosis and brain developmental trajectories. Mol Psychiatry. 12:195-205.
3. Akbarian S, Huang HS. 2006. Molecular and cellular mechanisms of altered GAD1/GAD67 expression in schizophrenia and related disorders. Brain Res Rev. 52:293-304.
4. Ayalew M, Le-Niculescu H, Levey DF, Jain N, Changala B, Patel SD, Winiger E, Breier A, Shekhar A, Amdur R et al. 2012. Convergent functional genomics of schizophrenia: from comprehensive understanding to genetic risk prediction. Mol Psychiatry. 17:887-905.
5. Biffi A, Anderson CD, Desikan RS, Sabuncu M, Cortellini L, Schmans-ky N, Salat D, Rosand J ADNI. 2010. Genetic variation and neuroi-maging measures in Alzheimer disease. Arch Neurol. 67:677-685.
6. Bigos K, Weinberger D. 2010. Imaging genetics-days of future past. Neuroimage. 53:804-809.
7. Boccardi M, Scassellati C, Ghidoni R, Testa C, Benussi L, Bonetti M, Bocchio-Chiavetto L, Gennarelli M, Binetti G, Frisoni GB. 2008. Effect of the XbaI polymorphism of estrogen receptor alpha on postmenopausal gray matter. Neurosci Lett. 434:304-309.
8. Bora E, Fornito A, Radua J, Walterfang M, Seal M, Wood SJ, Yucel M, Velakoulis D, Pantelis C. 2011. Neuroanatomical abnormalities in schizophrenia: a multimodal voxelwise meta-analysis and meta-regression analysis. Schizophr Res. 127:46-57.
9. Brauns S, Gollub RL, Roffman JL, Yendiki A, Ho BC, Wassink TH, Heinz A, Ehrlich S. 2011. DISC1 is associated with cortical thickness and neural efficiency. Neuroimage. 57:1591-1600.
10. Brody BA, Kinney HC, Kloman AS, Gilles FH. 1987. Sequence of central nervous system myelination in human infancy. I. An autopsy study of myelination. J Neuropathol Exp Neurol. 46:283-301.
11. Bueller JA, Aftab M, Sen S, Gomez-Hassan D, Burmeister M, Zubieta JK. 2006. BDNF val(66) met allele is associated with reduced hip-pocampal volume in healthy subjects. Biol Psychiatry. 59:812-815.
12. Buonanno A. 2010. The neuregulin signaling pathway and schizophrenia: from genes to synapses and neural circuits. Brain Res Bull. 83:122-131.
13. Burdick KE, Kamiya A, Hodgkinson CA, Lencz T, DeRosse P, Ishizuka K, Elashvili S, Arai H, Goldman D, Sawa A et al. 2008. Elucidating the relationship between DISC1, NDEL1 and NDE1 and the risk for schizophrenia: evidence of epistasis and competitive binding. Hum Mol Genet. 17:2462-2473.
14. Burggren AC, Zeineh MM, Ekstrom AD, Braskie MN, Thompson PM, Small GW, Bookheimer SY. 2008. Reduced cortical thickness in hippocampal subregions among cognitively normal apolipopro-tein E e4 carriers. Neuroimage. 41:1177-1183.
15. Cannon TD, Hennah W, van Erp TG, Thompson PM, Lonnqvist J, Huttunen M, Gasperoni T, Tuulio-Henriksson A, Pirkola T, Toga AW et al. 2005. Association of DISC1/TRAX haplotypes with schizophrenia, reduced prefrontal gray matter, and impaired short-and long-term memory. Arch Gen Psychiatry. 62:1205-1213.
16. Cao J. 1999. The size of the connected components of excursion sets of chi(2), t and F fields. Adv Appl Probab. 31:579-595.
17. Cerasa A, Gioia MC, Labate A, Liguori M, Lanza P, Quattrone A. 2008. Impact of catechol-O-methyltransferase Val(108/158) Met genotype on hippocampal and prefrontal gray matter volume. Neuroreport. 19:405-408.
18. Chapman S, Michaelson DM. 1998. Specific neurochemical derangements of brain projecting neurons in apolipoprotein E-deficient mice. J Neurochem. 70:708-714.
19. Chen JS, Lipska BK, Halim N, Ma QD, Matsumoto M, Melhem S, Kola-chana BS, Hyde TM, Herman MM, Apud J et al. 2004. Functional analysis of genetic variation in catechol-O-methyltransferase (COMT): effects on mRNA, protein, and enzyme activity in postmortem human brain. Am J Hum Genet. 75:807-821.
20. Cherlyn SY, Woon PS, Liu JJ, Ong WY, Tsai GC, Sim K. 2010. Genetic association studies of glutamate, GABA and related genes in schizophrenia and bipolar disorder: a decade of advance. Neuro-sci Biobehav Rev. 34:958-977.
21. Cheung C, Yu K, Fung G, Leung M, Wong C, Li Q, Sham P, Chua S, McAlonan G. 2010. Autistic disorders and schizophrenia: related or remote? An anatomical likelihood estimation. Plos One. 5: e12233.
22. Corbo RM, Scacchi R. 1999. Apolipoprotein E (APOE) allele distribution in the world. Is APOE*4 a 'thrifty' allele? Ann Hum Genet. 63:301-310.
23. Corder EH, Saunders AM, Strittmatter WJ, Schmechel DE, Gaskell PC, Small GW, Roses AD, Haines JL, Pericakvance MA. 1993. Gene dose of apolipoprotein-E type-4 allele and the risk of Alzheimers-disease in late-onset families. Science. 261:921-923.
24. Cox RW. 1996. AFNI: software for analysis and visualization of functional magnetic resonance neuroimages. Comput Biomed Res. 29:162-173
25. den Heijer T, Schuit SC, Pols HA, van Meurs JB, Hofman A, Koudstaal PJ, van Duijn CM, Uitterlinden AG, Breteler MM. 2004. Variations in estrogen receptor alpha gene and risk of dementia, and brain volumes on MRI. Mol Psychiatry. 9:1129-1135.
26. Dong LM, Weisgraber KH. 1996. Human apolipoprotein E4 domain interaction. Arginine 61 and glutamic acid 255 interact to direct the preference for very low density lipoproteins. J Biol Chem. 271:19053-19057.
27. Dumontheil I, Roggeman C, Ziermans T, Peyrard-Janvid M, Matsson H, Kere J, Klingberg T. 2011. Influence of the COMT genotype on working memory and brain activity changes during development. Biol Psychiatry. 70:222-229.
28. Eastwood SL, Hodgkinson CA, Harrison PJ. 2009. DISC-1 Leu607Phe alleles differentially affect centrosomal PCM1 localization and neurotransmitter release. Mol Psychiatry. 14:556-557.
29. Ekelund J, Hennah W, Hiekkalinna T, Parker A, Meyer J, Lonnqvist J, Peltonen L. 2004. Replication of 1q42 linkage in Finnish schizophrenia pedigrees. Mol Psychiatry. 9:1037-1041.
30. Ellison-Wright I, Bullmore E. 2010. Anatomy of bipolar disorder and schizophrenia: a meta-analysis. Schizophr Res. 117:1-12.
31. Fatemi SH, Folsom TD. 2009. The neurodevelopmental hypothesis of schizophrenia, revisited. Schizophr Bull. 35:528-548.
32. Fornito A, Yucel M, Patti J, Wood SJ, Pantelis C. 2009. Mapping grey matter reductions in schizophrenia: an anatomical likelihood estimation analysis of voxel-based morphometry studies. Schizophr Res. 108:104-113.
33. Frodl T, Schuele C, Schmitt G, Born C, Baghai T, Zill P, Bottlender R, Rupprecht R, Bondy B, Reiser M et al. 2007. Association of the brain-derived neurotrophic factor Val66Met polymorphism with reduced hippocampal volumes in major depression. Arch Gen Psychiatry. 64:410-416.
34. Fukumoto N, Fujii T, Combarros O, Kamboh MI, Tsai SJ, Matsushita S, Nacmias B, Comings DE, Arboleda H, Ingelsson M et al. 2010. Sexually dimorphic effect of the Val66Met polymorphism of BDNF on susceptibility to Alzheimer's disease: new data and meta-analysis. Am J Med Genet B Neuropsychiatr Genet. 153B:235-242.
35. Gaunt TR, Rodriguez S, Day I. 2007. Cubic exact solutions for the estimation of pairwise haplotype frequencies: implications for linkage disequilibrium analyses and a web tool 'CubeX'. BMC Bioinformatics. 8:428.
36. Georgieva L, Dimitrova A, Ivanov D, Nikolov I, Williams NM, Grozeva D, Zaharieva I, Toncheva D, Owen MJ, Kirov G et al. 2008. Support for neuregulin 1 as a susceptibility gene for bipolar disorder and schizophrenia. Biol Psychiatry. 64:419-427.
37. Gibbons AS, Udawela M, Jeon WJ, Seo MS, Brooks L, Dean B. 2011. The neurobiology of APOE in schizophrenia and mood disorders. Front Biosci. 16:962-979
38. Gilmore JH, Kang C, Evans DD, Wolfe HM, Smith JK, Lieberman JA, Lin W, Hamer RM, Styner M, Gerig G. 2010. Prenatal and neonatal brain structure and white matter maturation in children at high risk for schizophrenia. Am J Psychiatry. 167:1083-1091.
39. Gilmore JH, Lin W, Prastawa MW, Looney CB, Vetsa YSK, Knickmeyer RC, Evans DD, Smith JK, Hamer RM, Lieberman JA et al. 2007 Regional gray matter growth, sexual dimorphism, and cerebral asymmetry in the neonatal brain. J Neurosci. 27:1255-1260.
40. Gilmore JH, Shi F, Woolson SL, Knickmeyer RC, Short SJ, Lin W, Zhu H, Hamer RM, Styner M, Shen D. 2011. Longitudinal development of cortical and subcortical gray matter from birth to 2 years. Cereb Cortex. 22:2478-2485.
41. Gratacos M, Gonzalez JR, Mercader JM, de Cid R, Urretavizcaya M, Estivill X. 2007. Brain-derived neurotrophic factor Val66Met and psychiatric disorders: meta-analysis of case-control studies confirm association to substance-related disorders, eating disorders, and schizophrenia. Biol Psychiatry. 61:911-922.
42. Grumbach MM, Hughes IA, Conte FA. 2003. Williams textbook of endocrinology. In: Larsen P, Kronenberg H, Melmed S, Polonsky K, editors. Williams textbook of endocrinology. 10th ed. Philadelphia: Saunders. p. 842-969.
43. Hashimoto R, Numakawa T, Ohnishi T, Kumamaru E, Yagasaki Y, Ishimoto T, Mori T, Nemoto K, Adachi N, Izumi A et al. 2006. Impact of the DISC1 Ser704Cys polymorphism on risk for major depression, brain morphology and ERK signaling. Hum Mol Genet. 15:3024-3033.
44. Hayasaka S, Phan KL, Liberzon I, Worsley KJ, Nichols TE. 2004. Non-stationary cluster-size inference with random field and permutation methods. Neuroimage. 22:676-687.
45. Hazlett HC, Poe M, Gerig G, Smith RG, Provenzale J, Ross A, Gilmore J, Piven J. 2005. Magnetic resonance Imaging and head circumference study of brain size in autism-birth through age 2 years. Arch Gen Psychiatry. 62:1366-1376.
46. Hazlett HC, Poe MD, Gerig G, Styner M, Chappell C, Smith RG, Vachet C, Piven J. 2011. Early brain overgrowth in autism associated with an increase in cortical surface area before age 2 years. Arch Gen Psychiatry. 68:467-476.
47. Hennah W, Thomson P, McQuillin A, Bass N, Loukola A, Anjorin A, Blackwood D, Curtis D, Deary IJ, Harris SE et al. 2009. DISC1 association, heterogeneity and interplay in schizophrenia and bipolar disorder. Mol Psychiatry. 14:865-873.
48. Hennah W, Varilo T, Kestila M, Paunio T, Arajarvi R, Haukka J, Parker A, Martin R, Levitzky S, Partonen T et al. 2003. Haplotype transmission analysis provides evidence of association for DISC1 to schizophrenia and suggests sex-dependent effects. Hum Mol Genet. 12:3151-3159.
49. Henseler I, Falkai P, Gruber O 2010. Disturbed functional connectivity within brain networks subserving domain-specific subcomponents of working memory in schizophrenia: relation to performance and clinical symptoms. J Psychiatr Res. 44:364-372.
50. Ho BC, Milev P, O'Leary DS, Librant A, Andreasen NC, Wassink TH. 2006. Cognitive and magnetic resonance imaging brain morpho-metric correlates of brain-derived neurotrophic factor Val66Met gene polymorphism in patients with schizophrenia and healthy volunteers. Arch Gen Psychiatry. 63:731-740.
51. Hodgkinson CA, Goldman D, Jaeger J, Persaud S, Kane JM, Lipsky RH, Malhotra AK. 2004. Disrupted in schizophrenia 1 (DISC1): association with schizophrenia, schizoaffective disorder, and bipolar disorder. Am J Hum Genet. 75:862-872.
52. Hoffmann I, Bueter W, Zscheppang K, Brinkhaus MJ, Liese A, Riemke S, Dork T, Dammann O, Dammann CEL. 2011. Neuregulin-1, the fetal endothelium, and brain damage in preterm newborns (vol 24, pg 784, 2010). Brain Behav Immun. 25:1044-.
53. Hong CJ, Liou YJ, Tsai SJ. 2011. Effects of BDNF polymorphisms on brain function and behavior in health and disease. Brain Res Bull. 86:287-297.
54. Hosak L, Silhan P, Hosakova J. 2012. Genomic copy number variations: a breakthrough in our knowledge on schizophrenia etiology? Neuroendocrinol Lett. 33:183-190.
55. Hua X, Leow AD, Parikshak N, Lee S, Chiang MC, Toga AW, Jack CR Jr, Weiner MW, Thompson PM. 2008. Tensor-based morphometry as a neuroimaging biomarker for Alzheimer's disease: an MRI study of 676 AD, MCI, and normal subjects. Neuroimage. 43:458-469.
56. Huttenlocher PR, Dabholkar AS. 1997. Regional differences in synaptogenesis in human cerebral cortex. J Comp Neurol. 387:167-178.
57. Johnstone M, Thomson PA, Hall J, McIntosh AM, Lawrie SM, Porteous DJ. 2011. DISC1 in schizophrenia: genetic mouse models and human genomic imaging. Schizophr Bull. 37:14-20.
58. Joshi S, Davis B, Jomier M, Gerig G. 2004. Unbiased diffeomorphic atlas construction for computational anatomy. Neuroimage. 23(1): S151-160.
59. Karlsgodt KH, van Erp TG, Poldrack RA, Bearden CE, Nuechterlein KH, Cannon TD. 2008. Diffusion tensor imaging of the superior lo6ngitudinal fasciculus and working memory in recent-onset schizophrenia. Biol Psychiatry. 63:512-518.
60. Kasprian G, Brugger PC, Weber M, Krssak M, Krampl E, Herold C, Prayer D. 2008. In utero tractography of fetal white matter development. Neuroimage. 43:213-224.
61. Kilpinen H, Ylisaukko-Oja T, Hennah W, Palo OM, Varilo T, Vanhala R, Wendt TNV, von Wendt L, Paunio T, Peltonen L. 2008. Association of DISC1 with autism and Asperger syndrome. Mol Psychiatry. 13:187-196.
62. Knickmeyer R, Gouttard S, Kang C, Evans D, Wilber K, Smith JK, Hamer RM, Lin W, Gerig G, Gilmore JH. 2008. A structural MRI study of human brain development from birth to 2 years. J Neuro-sci. 28:12176-12182.
63. Law AJ, Lipska BK, Weickert CS, Hyde TM, Straub RE, Hashimoto R, Harrison PJ, Kleinman JE, Weinberger DR. 2006. Neuregulin 1 transcripts are differentially expressed in schizophrenia and regulated by 5′ SNPs associated with the disease. Proc Natl Acad Sci USA. 103:6747-6752.
64. Leliveld SR, Hendriks P, Michel M, Sajnani G, Bader V, Trossbach S, Prikulis I, Hartmann R, Jonas E, Willbold D et al. 2009. Oligomer assembly of the C-terminal DISC1 domain (640-854) is controlled by self-association motifs and disease-associated polymorphism S704C. Biochemistry (Mosc). 48:7746-7755.
65. Lemaitre H, Crivello F, Dufouil C, Grassiot B, Tzourio C, Alperovitch A, Mazoyer B. 2005. No epsilon(4) gene dose effect on hippocam-pal atrophy in a large MRI database of healthy elderly subjects. Neuroimage. 24:1205-1213.
66. Lepore N, Brun C, Chou YY, Chiang MC, Dutton RA, Hayashi KM, Luders E, Lopez OL, Aizenstein HJ, Toga AW et al. 2008. Generalized tensor-based morphometry of HIV/AIDS using multivariate statistics on deformation tensors. IEEE Trans Med Imaging. 27:129-141.
67. Levi O, Jongen-Relo AL, Feldon J, Michaelson DM. 2005. Brain area-and isoform-specific inhibition of synaptic plasticity by apoE4. J Neurol Sci. 229-230:241-248.
68. Lewandowski KE. 2007. Relationship of catechol-O-methyltransferase to schizophrenia and its correlates: evidence for associations and complex interactions. Harv Rev Psychiatry. 15:233-244.
69. Li D, Collier DA, He L. 2006. Meta-analysis shows strong positive association of the neuregulin 1 (NRG1) gene with schizophrenia. Hum Mol Genet. 15:1995-2002.
70. Li YM, Zhu HT, Shen DG, Lin WL, Gilmore JH, Ibrahim JG. 2011. Multiscale adaptive regression models for neuroimaging data. J Roy Stat Soc B. 73:559-578.
71. Liang KY, Zeger SL. 1986. Longitudinal data-analysis using generalized linear-models. Biometrika. 73:13-22.
72. Mahley RW, Huang Y. 2006. Apolipoprotein (apo) E4 and Alzheimer's disease: unique conformational and biophysical properties of apoE4 can modulate neuropathology. Acta Neurol Scand Suppl. 185:8-14.
73. Malavasi EL, Ogawa F, Porteous DJ, Millar JK. 2012. DISC1 variants 37W and 607F disrupt its nuclear targeting and regulatory role in ATF4-mediated transcription. Hum Mol Genet. 21:2779-2792.
74. Maruyama H, Toji H, Harrington CR, Sasaki K, Izumi Y, Ohnuma T, Arai H, Yasuda M, Tanaka C, Emson PC et al. 2000. Lack of an association of estrogen receptor alpha gene polymorphisms and transcriptional activity with Alzheimer disease. Arch Neurol. 57:236-240.
75. Mata I, Perez-Iglesias R, Roiz-Santianez R, Tordesillas-Gutierrez D, Gonzalez-Mandly A, Vazquez-Barquero JL, Crespo-Facorro B. 2009. A neuregulin 1 variant is associated with increased lateral ventricle volume in patients with first-episode schizophrenia. Biol Psychiatry. 65:535-540.
76. McIntosh AM, Baig BJ, Hall J, Job D, Whalley HC, Lymer GK, Moor-head TW, Owens DG, Miller P, Porteous D et al. 2007. Relationship of catechol-O- methyltransferase variants to brain structure and function in a population at high risk of psychosis. Biol Psychiatry. 61:1127-1134.
77. Mechelli A, Tognin S, McGuire PK, Prata D, Sartori G, Fusar-Poli P, De Brito S, Hariri AR, Viding E. 2009. Genetic vulnerability to affective psychopathology in childhood: a combined voxel-based mor-phometry and functional magnetic resonance imaging study. Biol Psychiatry. 66:231-237.
78. Mei L, Xiong WC. 2008. Neuregulin 1 in neural development, synaptic plasticity and schizophrenia. Nat Rev Neurosci. 9:437-452.
79. Meyer-Lindenberg A, Nichols T, Callicott JH, Ding J, Kolachana B, Buckholtz J, Mattay VS, Egan M, Weinberger DR. 2006. Impact of complex genetic variation in COMT on human brain function. Mol Psychiatry. 11:867-877, 797.
80. Meyer-Lindenberg A, Weinberger DR. 2006. Intermediate phenotypes and genetic mechanisms of psychiatric disorders. Nat Rev Neuro-sci. 7:818-827.
81. Montag C, Weber B, Fliessbach K, Elger C, Reuter M. 2009. The BDNF Val66Met polymorphism impacts parahippocampal and amygdala volume in healthy humans: incremental support for a genetic risk factor for depression. Psychol Med. 39:1831-1839.
82. Munoz A, Rosner B, Carey V. 1986. Regression-analysis in the presence of heterogeneous intraclass correlations. Biometrics. 42:653-658.
83. Ohnishi T, Hashimoto R, Mori T, Nemoto K, Moriguchi Y, Iida H, Noguchi H, Nakabayashi T, Hori H, Ohmori M et al. 2006. The association between the Val158Met polymorphism of the catechol-O-methyl transferase gene and morphological abnormalities of the brain in chronic schizophrenia. Brain. 129:399-410.
84. Patel SD, Le-Niculescu H, Koller DL, Green SD, Lahiri DK, McMahon FJ, Nurnberger JI Jr, Niculescu AB III. 2010. Coming to grips with complex disorders: genetic risk prediction in bipolar disorder using panels of genes identified through convergent functional genomics. Am J Med Genet B Neuropsychiatr Genet. 153B:850-877.
85. Peled A, Geva AB, Kremen WS, Blankfeld HM, Esfandiarfard R, Nordahl TE. 2001. Functional connectivity and working memory in schizophrenia: an EEG study. Int J Neurosci. 106:47-61.
86. Petanjek Z, Judas M, Kostovic I, Uylings HBM. 2008. Lifespan alterations of basal dendritic trees of pyramidal neurons in the human prefrontal cortex: a layer-specific pattern. Cereb Cortex. 18:915-929.
87. Pezawas L, Verchinski BA, Mattay VS, Callicott JH, Kolachana BS, Straub RE, Egan MF, Meyer-Lindenberg A, Weinberger DR. 2004. The brain-derived neurotrophic factor val66met polymorphism and variation in human cortical morphology. J Neurosci. 24:10099-10102.
88. Plassman BL, WelshBohmer KA, Bigler ED, Johnson SC, Anderson CV, Helms MJ, Saunders AM, Breitner JCS. 1997. Apolipoprotein E epsilon 4 allele and hippocampal volume in twins with normal cognition. Neurology. 48:985-989.
89. Porteous DJ, Millar JK, Brandon NJ, Sawa A. 2011. DISC1 at 10: connecting psychiatric genetics and neuroscience. Trends Mol Med. 17:699-706.
90. Prastawa M, Gilmore JH, Lin WL, Gerig G. 2005. Automatic segmentation of MR images of the developing newborn brain. Med Image Anal. 9:457-466.
91. Prata DP, Breen G, Osborne S, Munro J, St Clair D, Collier DA. 2009. An association study of the neuregulin 1 gene, bipolar affective disorder and psychosis. Psychiatr Genet. 19:113-116.
92. Qu M, Tang FL, Yue WH, Ruan Y, Lu TL, Liu ZH, Zhang HD, Han YH, Zhang DR, Wang F et al. 2007. Positive association of the disrupted-in-schizophrenia-1 gene (DISC1) with schizophrenia in the Chinese Han Population. Am J Med Genet B. 144B:266-270.
93. Rapoport JC, Addington AM, Frangou S. 2005. The neurodevelopmental model of schizophrenia: update 2005. Mol Psychiatry. 10:614.
94. Rasetti R, Weinberger DR. 2011. Intermediate phenotypes in psychiatric disorders. Curr Opin Genet Dev. 21:340-348.
95. Raznahan A, Greenstein D, Lee Y, Long R, Clasen L, Gochman P, Ad-dington A, Giedd JN, Rapoport JL, Gogtay N. 2011. Catechol-O-methyl transferase (COMT) val158met polymorphism and adolescent cortical development in patients with childhood-onset schizophrenia, their non-psychotic siblings, and healthy controls. Neuroimage. 57:1517-1523.
96. Raznahan A, Lee Y, Long R, Greenstein D, Clasen L, Addington A, Rapoport JL, Giedd JN. 2011. Common functional polymorphisms of DISC1 and cortical maturation in typically developing children and adolescents. Mol Psychiatry. 16:917-926.
97. Reichardt LF. 2006. Neurotrophin-regulated signalling pathways. Philos T R Soc B. 361:1545-1564.
98. Scharinger C, Rabl U, Sitte HH, Pezawas L. 2010. Imaging genetics of mood disorders. Neuroimage. 53:810-821.
99. Schiepers OJ, Harris SE, Gow AJ, Pattie A, Brett CE, Starr JM, Deary IJ. 2012. APOE E4 status predicts age-related cognitive decline in the ninth decade: longitudinal follow-up of the Lothian Birth Cohort 1921. Mol Psychiatry. 17:315-324.
100. Selvaraj S, Arnone D, Job D, Stanfield A, Farrow TF, Nugent AC, Scherk H, Gruber O, Chen X, Sachdev PS et al. 2012. Grey matter differences in bipolar disorder: a meta-analysis of voxel-based morphometry studies. Bipolar Disord. 14:135-145.
101. Shaw P, Lerch JP, Pruessner JC, Taylor KN, Rose AB, Greenstein D, Clasen L, Evans A, Rapoport JL, Giedd JN. 2007. Cortical morphology in children and adolescents with different apolipoprotein E gene polymorphisms: an observational study. Lancet Neurol. 6:494-500.
102. Shaw P, Wallace GL, Addington A, Evans A, Rapoport J, Giedd JN. 2009. Effects of the Val(158)Met catechol-O-methyltransferase polymorphism on cortical structure in children and adolescents. Mol Psychiatry. 14:348-349.
103. Shibuya M, Komi E, Wang R, Kato T, Watanabe Y, Sakai M, Ozaki M, Someya T, Nawa H. 2010. Measurement and comparison of serum neuregulin 1 immunoreactivity in control subjects and patients with schizophrenia: an influence of its genetic polymorphism. J Neural Transm. 117:887-895.
104. Small SA, Schobel SA, Buxton RB, Witter MP, Barnes CA. 2011. A pathophysiological framework of hippocampal dysfunction in ageing and disease. Nat Rev Neurosci. 12:585-601.
105. Sundermann EE, Maki PM, Bishop JR. 2010. A review of estrogen receptor alpha gene (ESR1) polymorphisms, mood, and cognition. Menopause. 17:874-886.
106. Szeszko PR, Hodgkinson CA, Robinson DG, DeRosse P, Bilder RM, Lencz T, Burdick KE, Napolitano B, Betensky JD, Kane JA et al. 2008. DISC1 is associated with prefrontal cortical gray matter and positive symptoms in schizophrenia. Biol Psychol. 79:103-110.
107. Takahashi T, Suzuki M, Tsunoda M, Kawamura Y, Takahashi N, Tsuneki H, Kawasaki Y, Zhou SY, Kobayashi S, Sasaoka T et al. 2008. Association between the brain-derived neurotrophic factor Val66Met polymorphism and brain morphology in a Japanese sample of schizophrenia and healthy comparisons. Neurosci Lett. 435:34-39.
108. Takahashi T, Suzuki M, Tsunoda M, Maeno N, Kawasaki Y, Zhou SY, Hagino H, Niu L, Tsuneki H, Kobayashi S et al. 2009. The disrupted-in-schizophrenia-1 Ser704Cys polymorphism and brain morphology in schizophrenia. Psychiat Res-Neuroim. 172:128-135.
109. Takeda M, Martinez R, Kudo T, Tanaka T, Okochi M, Tagami S, Mor-ihara T, Hashimoto R, Cacabelos R. 2010. Apolipoprotein E and central nervous system disorders: reviews of clinical findings. Psy-chiatr Clin Neurosci. 64:592-607.
110. Tan HY, Callicott JH, Weinberger DR. 2008. Intermediate phenotypes in schizophrenia genetics redux: is it a no brainer? Mol Psychiatry. 13:233-238.
111. Tan W, Wang Y, Gold B, Chen J, Dean M, Harrison PJ, Weinberger DR, Law AJ. 2007. Molecular cloning of a brain-specific, develop-mentally regulated neuregulin 1 (NRG1) isoform and identification of a functional promoter variant associated with schizophrenia. J Biol Chem. 282:24343-24351.
112. Taylor AE, Guthrie PAI, Smith GD, Golding J, Sattar N, Hingorani AD, Deanfield JE, Day INM. 2011. IQ, educational attainment, memory and plasma lipids: associations with apolipoprotein E genotype in 5995 children. Biol Psychiatry. 70:152-158.
113. Taylor WD, Zuchner S, Payne ME, Messer DF, Doty TJ, MacFall JR, Beyer JL, Krishnan KRR. 2007. The COMT Val 158Met polymorphism and temporal lobe morphometry in healthy adults. Psychiat Res-Neuroim. 155:173-177.
114. Tosato S, Bellani M, Bonetto C, Ruggeri M, Perlini C, Lasalvia A, Marinelli V, Rambaldelli G, Cristofalo D, Bertani M et al. 2012. Is neuregulin1 involved in determining cerebral volumes in schizophrenia? Preliminary results showing a decrease in superior temporal gyrus volume. Neuropsychobiology. 65:119-125.
115. Tzourio-Mazoyer N, Landeau B, Papathanassiou D, Crivello F, Etard O, Delcroix N, Mazoyer B, Joliot M. 2002. Automated anatomical labeling of activations in SPM using a macroscopic anatomical par-cellation of the MNI MRI single-subject brain. Neuroimage. 15:273-289.
116. Vance JE, Hayashi H. 2010. Formation and function of apolipoprotein E-containing lipoproteins in the nervous system. Bba-Mol Cell Biol L. 1801:806-818.
117. Verhagen M, van der Meij A, van Deurzen PA, Janzing JG, Arias-Vasquez A, Buitelaar JK, Franke B. 2010. Meta-analysis of the BDNF Val66Met polymorphism in major depressive disorder: effects of gender and ethnicity. Mol Psychiatry. 15:260-271.
118. Wang DD, Kriegstein AR. 2009. Defining the role of GABA in cortical development. J Physiol Lond. 587:1873-1879.
119. Wang F, Jiang T, Sun Z, Teng SL, Luo X, Zhu Z, Zang Y, Zhang H, Yue W, Qu M et al. 2009. Neuregulin 1 genetic variation and anterior cingulum integrity in patients with schizophrenia and healthy controls. J Psychiatry Neurosci. 34:181-186.
120. Weickert CS, Webster MJ, Gondipalli P, Rothmond D, Fatula RJ, Herman MM, Kleinman JE, Akil M. 2007. Postnatal alterations in dopaminergic markers in the human prefrontal cortex. Neuro-science. 144:1109-1119.
121. Westberg L, Eriksson E. 2008. Sex steroid-related candidate genes in psychiatric disorders. J Psychiatry Neurosci. 33:319-330.
122. Williams HJ, Owen MJ, O'Donovan MC. 2007. Is COMT a susceptibility gene for schizophrenia? Schizophr Bull. 33:635-641.
123. Winterer G, Konrad A, Vucurevic G, Musso F, Stoeter P, Dahmen N. 2008. Association of 5′ end neuregulin-1 (NRG1) gene variation with subcortical medial frontal microstructure in humans. Neuro-image. 40:712-718.
124. Wolff JJ, Gu H, Gerig G, Elison JT, Styner M, Gouttard S, Botteron KN, Dager SR, Dawson G, Estes AM et al. 2012. Differences in white matter fiber tract development present from 6 to 24 months in infants with autism. Am J Psychiatry. 169:589-600.
125. Worsley KJ, Andermann M, Koulis T, MacDonald D, Evans AC. 1999. Detecting changes in nonisotropic images. Hum Brain Mapp. 8:98-101.
126. Worsley K, Marrett S, Neelin P, Vandal AC, Friston K, Evans AC. 1996. A unified statistical approach for determining significant voxels in images of cerebral activation. Hum Brain Mapp. 4:58-73.
127. Wright RO, Hu H, Silverman EK, Tsaih SW, Schwartz J, Bellinger D, Palazuelos E, Weiss ST, Hernandez-Avila M. 2003. Apolipoprotein E genotype predicts 24-month Bayley scales infant development score. Pediatr Res. 54:819-825.
128. Yavich L, Forsberg MM, Karayiorgou M, Gogos JA, Mannisto PT. 2007. Site-specific role of catechol-O-methyltransferase in dopamine overflow within prefrontal cortex and dorsal striatum. J Neurosci. 27:10196-10209.
129. Yu K, Cheung C, Leung M, Li Q, Chua S, McAlonan G. 2010. Are bipolar disorder and schizophrenia neuroanatomically distinct? An anatomical likelihood meta-analysis. Front Hum Neurosci. 4:189.
130. Yushkevich PA, Piven J, Hazlett HC, Smith RG, Ho S, Gee JC, Gerig G. 2006. User-guided 3D active contour segmentation of anatomical structures: significantly improved efficiency and reliability. Neuroimage. 31:1116-1128.
131. Zhu HT, Li Y, Ibrahim JG, Lin W, Shen DG. 2009. MARM: multiscale adaptive regression for neuroimaging data. Inf Process Med Imaging. 21:314-325.